cnspharma / CNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://cnspharma.com/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	CNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments
Description	Berubicin CNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments for brain
Keywords	N/A

Server Information

WebSite	cnspharma.com
Host IP	104.21.84.239
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

cnspharma.com Valuation

US$10,242,134

Last updated: 2023-05-03 19:04:56

cnspharma.com has Semrush global rank of 1,033,408. cnspharma.com has an estimated worth of US$ 10,242,134, based on its estimated Ads revenue. cnspharma.com receives approximately 1,181,785 unique visitors each day. Its web server is located in United States, with IP address 104.21.84.239. According to SiteAdvisor, cnspharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$10,242,134
Daily Ads Revenue	US$9,455
Monthly Ads Revenue	US$283,629
Yearly Ads Revenue	US$3,403,540
Daily Unique Visitors	78,786
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
cnspharma.com.	A	300	IP: 104.21.84.239
cnspharma.com.	A	300	IP: 172.67.198.228
cnspharma.com.	AAAA	300	IPV6: 2606:4700:3036::ac43:c6e4
cnspharma.com.	AAAA	300	IPV6: 2606:4700:3034::6815:54ef
cnspharma.com.	NS	86400	NS Record: meera.ns.cloudflare.com.
cnspharma.com.	NS	86400	NS Record: newt.ns.cloudflare.com.
cnspharma.com.	MX	300	MX Record: 0 cnspharma-com.mail.protection.outlook.com.
cnspharma.com.	TXT	300	TXT Record: v=spf1 include:spf.protection.outlook.com -all
cnspharma.com.	TXT	300	TXT Record: NETORGFT3300689.onmicrosoft.com

HtmlToTextCheckTime:2023-05-03 19:04:56

Brain Glioblastoma Anthracyclines Blood Brain Barrier Technology Berubicin Pipeline Expanded Access Team Management Board About Us Contact Investors Sign Up Berubicin Based on human clinical trial data, our lead drug called Berubicin, which was developed at a leading U.S. comprehensive cancer center, has been shown to get across the blood brain barrier and kill brain tumor cells not reachable by other therapies. In other words, Berubicin may become an effective treatment against glioblastoma, the most aggressive type of brain cancer. Learn More BERUBICIN PHASE I CLINICAL TRIAL This is a scan of a patient’s glioblastoma in Berubicin’s Phase 1 clinical trial where 44% of the patients showed a clinical response. Berubicin is one of the first anthracycline’s that does not require a specific carrier to be able to cross over the blood brain barrier and get into the brain. None of the drugs that require carriers have been shown to be effective in humans. The image on the left is

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Tue, 26 Oct 2021 00:23:39 GMT
Content-Type: text/html
Connection: keep-alive
location: https://cnspharma.com/
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Hq%2Bv%2FmnojpY2ZBKK6d0qV7uDrzJgn0DaRpcRLIemPqjxxj52OLWWZio6yktIJp9N62sAyDQlXWkyWVil2aKNCNdM83dJM2k%2F5hR1D5taBQ4CFVZMGrVuvJHNe0c4V2Y6"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a3f89887baa6314-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Tue, 26 Oct 2021 00:23:39 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
vary: Accept-Encoding,Cookie
x-pingback: https://cnspharma.com/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
cache-control: max-age=600, must-revalidate
x-cache: HIT: 3
x-cache-group: normal
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=xuNz968U0oN4y7636%2BRDKATYZ7gfn52rNR9YjqBEHmNboqVDqXDnrUBC3mFXdAp3pyFOD8Dlbv2yHOdoEz9tQZ17CovB%2B%2B458Ur%2Fj2fR%2FQ2CAPOs%2FdfGg1RnfcOCwt8W"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a3f898929b203bc-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

cnspharma.com Whois Information

Domain Name: CNSPHARMA.COM
Registry Domain ID: 2027854004_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-05-13T11:28:38Z
Creation Date: 2016-05-13T00:07:55Z
Registry Expiry Date: 2022-05-13T00:07:55Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: MEERA.NS.CLOUDFLARE.COM
Name Server: NEWT.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-14T02:02:37Z <<<

cnspharma.com valuation and analysis